Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of depression, special category of depression demonstrated by a unique genetically determined abnormality in seratonin metabolism; Pharmaceutical preparations namely, antidepressants; Pharmaceuticals, namely, psychotropics